Progress Report: Double-blind, Placebo-control, Cross-over Trial of Cannabidiol for Essential Tremor

Principal Investigator: Fatta Nahab, M.D., associate professor, University of California, San Diego

January 2019 Update

We have made significant progress on our work. We have received our Drug Enforcement Agency (DEA)  import license and our pharmaceutical partner, Tilray, obtained their export license. The drug product and matching placebo capsules were manufactured. The product was shipped to us in mid-December and after a complex series of regulatory hurdles, we received delivery.

We have received an enormous interest in the study from prospective participants. We completed pre-screening of 200 subjects and the first 10 eligible to participate are now being scheduled.